Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Radiologic-pathologic correlation of renal cell carcinoma associated with Xp11.2 translocation.

Koo HJ, Choi HJ, Kim MH, Cho KS.

Acta Radiol. 2013 Sep;54(7):827-34. doi: 10.1177/0284185113484019. Epub 2013 May 9.

PMID:
23761541
2.

MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.

Woo S, Kim SY, Lee MS, Moon KC, Kim SH, Cho JY, Kim SH.

AJR Am J Roentgenol. 2015 Mar;204(3):542-9. doi: 10.2214/AJR.14.12950.

PMID:
25714283
3.

Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions: findings on MRI and computed tomography imaging.

Liu K, Xie P, Peng W, Zhou Z.

J Magn Reson Imaging. 2014 Aug;40(2):440-7. doi: 10.1002/jmri.24349. Epub 2013 Oct 17.

PMID:
24136829
4.

The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.

Zhu QQ, Wang ZQ, Zhu WR, Chen WX, Wu JT.

Acta Radiol. 2013 Apr 1;54(3):355-62. doi: 10.1258/ar.2012.120255. Epub 2013 Feb 27.

PMID:
23446748
5.

Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Wang W, Ding J, Li Y, Wang C, Zhou L, Zhu H, Peng W.

PLoS One. 2014 Jun 13;9(6):e99990. doi: 10.1371/journal.pone.0099990. eCollection 2014.

6.

Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients.

Chen X, Zhu Q, Li B, Cui W, Zhou H, Duan N, Liu Y, Kundra V, Wang Z.

Eur Radiol. 2017 Feb;27(2):543-552. doi: 10.1007/s00330-016-4421-4. Epub 2016 Jun 2.

PMID:
27255396
7.

Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions: Comparison With Clear Cell Renal Cell Carcinoma.

He J, Gan W, Liu S, Zhou K, Zhang G, Guo H, Zhu B.

J Comput Assist Tomogr. 2015 Sep-Oct;39(5):730-6. doi: 10.1097/RCT.0000000000000263.

PMID:
25955396
8.

Renal carcinomas associated with Xp11.2 translocations: are CT findings suggestive of the diagnosis?

He J, Huan Y, Qiao Q, Zhang J, Zhang JS.

Clin Radiol. 2014 Jan;69(1):45-51. doi: 10.1016/j.crad.2013.08.004. Epub 2013 Oct 22.

PMID:
24156792
9.

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.

He J, Zhou K, Zhu B, Zhang G, Li X, Guo H, Gan W, Zhou Z, Liu T.

Biomed Res Int. 2015;2015:298679. doi: 10.1155/2015/298679. Epub 2015 Nov 9.

10.
11.

Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.

Kim JK, Park SY, Shon JH, Cho KS.

Radiology. 2004 Mar;230(3):677-84.

PMID:
14990834
12.

Clinico-radio-pathologic features of a solitary solid renal mass at MDCT examination.

Kim EY, Park BK, Kim CK, Lee HM.

Acta Radiol. 2010 Dec;51(10):1143-8. doi: 10.3109/02841851.2010.515617. Epub 2010 Sep 19.

PMID:
20849320
13.

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.

Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.

PMID:
23598965
14.

Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.

Honda Y, Goto K, Nakamura Y, Terada H, Sentani K, Yasui W, Sekino Y, Hayashi T, Teishima J, Matsubara A, Fuji T, Kaichi Y, Higaki T, Baba Y, Iida M, Awai K.

Abdom Radiol (NY). 2017 Jul;42(7):1850-1856. doi: 10.1007/s00261-017-1189-1.

PMID:
28534069
15.

Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.

Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, Narimatsu Y, Murai M.

J Comput Assist Tomogr. 2000 Nov-Dec;24(6):835-42.

PMID:
11105696
16.

XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.

Hung CC, Pan CC, Lin CC, Lin AT, Chen KK, Chang YH.

J Chin Med Assoc. 2011 Nov;74(11):500-4. doi: 10.1016/j.jcma.2011.09.005. Epub 2011 Nov 1.

17.

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.

Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2007 Aug;31(8):1149-60.

PMID:
17667536
18.

Clinicopathological features of Xp11.2 translocation renal cell carcinoma.

Lim B, You D, Jeong IG, Kwon T, Hong S, Song C, Cho YM, Hong B, Hong JH, Ahn H, Kim CS.

Korean J Urol. 2015 Mar;56(3):212-7. doi: 10.4111/kju.2015.56.3.212. Epub 2015 Feb 26.

19.

Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.

Lee-Felker SA, Felker ER, Tan N, Margolis DJ, Young JR, Sayre J, Raman SS.

AJR Am J Roentgenol. 2014 Nov;203(5):W516-24. doi: 10.2214/AJR.14.12460.

PMID:
25341166
20.

CT and US findings of multilocular cystic renal cell carcinoma.

Kim JC, Kim KH, Lee JW.

Korean J Radiol. 2000 Apr-Jun;1(2):104-9.

Supplemental Content

Support Center